Found: 8
Select item for more details and to access through your institution.
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?
- Published in:
- Journal of Gene Medicine, 2008, v. 10, n. 9, p. 1032, doi. 10.1002/jgm.1221
- By:
- Publication type:
- Article
Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial.
- Published in:
- Journal of Cancer Survivorship, 2013, v. 7, n. 4, p. 551, doi. 10.1007/s11764-013-0294-6
- By:
- Publication type:
- Article
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
- Published in:
- British Journal of Cancer, 2007, v. 96, n. 10, p. 1587, doi. 10.1038/sj.bjc.6603767
- By:
- Publication type:
- Article
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.
- Published in:
- 2006
- By:
- Publication type:
- journal article
<sup>18</sup>FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.
- Published in:
- British Journal of Cancer, 2006, v. 95, n. 9, p. 1174, doi. 10.1038/sj.bjc.6603412
- By:
- Publication type:
- Article
Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Comparison of two fractionation regimens in the multimodal therapy of cancer of the esophagus.
- Published in:
- Diseases of the Esophagus, 2007, v. 20, n. 3, p. 217, doi. 10.1111/j.1442-2050.2007.00675.x
- By:
- Publication type:
- Article
Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer.
- Published in:
- Diseases of the Esophagus, 2006, v. 19, n. 4, p. 273, doi. 10.1111/j.1442-2050.2006.00576.x
- By:
- Publication type:
- Article